semaglutide trials near me Novo Nordisk announced headline results from STEP UP, a phase IIIb trial investigating subcutaneous 7.2 mg for obesity What the SELECT trial of

So why would anyone consider orforglipron at all

The FDA gave compounders until May to wind down

real-world data

in Nutrients compiled clinical and experimental evidence demonstrating that hydroxytyrosol improves lipid profiles, glycaemia, and insulin sensitivity while counteracting oxidative and inflammatory processes (Peyrol et al., 2017)

Common Adverse Events Researchers Track in Phase 2 and Phase 3 Across retatrutide side effects clinical trials queries, the same adverse-event cluster appears repeatedly: nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal pain, back pain, and fatigue or tiredness

Last medically reviewed: May 2026 Find the right provider for your needs select your state to find expert care near you.